Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P050027/S034

Photodynamic Diagnostic D-Light C System

Karl Storz Endoscopy-America, Inc. · Decision date Oct 1, 2025

FDA DECISIONP050027/S034

What did the FDA decide?

FDA records P050027/S034 as a supplement to PMA P050027, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 1, 2025.

FDA approval order statement

to replace the backside mirror coating from RSM 3950100 to RSM 3950108
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 1, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P050027/S034
Regulatory pathway
PMA supplement
Product code
OAY
Decision code
OK30
Decision date
Oct 1, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light source system, diagnostic endoscopic.

Product code
OAY
FDA device class
3

For the original device and its historical approval scope, see PMA P050027. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P050027 · Original PMA

    KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM

  2. P050027/S034 received

    Application receipt date recorded by FDA.

  3. P050027/S034 · FDA decision

    30-Day Notice

  4. P050027/S035 · Related supplement

    Photodynamic Diagnostic D-Light C (PDD) System

  5. P050027/S036 · Related supplement

    Photodynamic Diagnostic D-Light C System

  6. P050027/S038 · Related supplement

    Photodynamic Diagnostic D-Light C System

Timeline entries are records held by MedtechLedger for P050027. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P050027

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Karl Storz Endoscopy-America, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2151 E. Grand Ave., El Segundo, CA, 90245

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records